NCT03482440View on ClinicalTrials.gov

Angiotensin II and Chronic Inflammation in Persistent Microvascular Dysfunction Following Preeclampsia

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

August 26, 2018

Primary Completion Date

July 11, 2019

Study Completion Date

December 31, 2022

Conditions
Preeclampsia
Interventions
DRUG

Salsalate Oral Tablet

1500mg twice daily for 4 days prior to experimental testing

DRUG

Placebo Oral Tablet

Placebo oral table twice daily for 4 days prior to experimental testing

Trial Locations (2)

16802

Pennsylvania State University, University Park

52242

University of Iowa, Iowa City

All Listed Sponsors
collaborator

Penn State University

OTHER

lead

University of Iowa

OTHER

NCT03482440 - Angiotensin II and Chronic Inflammation in Persistent Microvascular Dysfunction Following Preeclampsia | Biotech Hunter | Biotech Hunter